Marshall Mazepa

Marshall Mazepa, MD, is an Associate Professor of Medicine at the University of Minnesota, affiliated with the Division of Hematology, Oncology and Transplantation. His research focuses on immune-mediated thrombotic disorders, particularly thrombotic thrombocytopenic purpura (TTP) and erythropoietic protoporphyria, with emphasis on clinical outcomes, biomarkers, and therapeutic innovations.

• Research Trends: Recent studies highlight caplacizumab, rituximab, and plasma exchange in TTP management, alongside investigations into liver dysfunction in protoporphyria, neurocognitive outcomes, and health disparities.
• Professional Context: Affiliated with the University of Minnesota's Hematology division, contributing to registry-based research (USTMA TTP Registry, IWG-TTP) and international clinical collaborations.